Rxo (RXO) Invested Capital (2021 - 2026)

Rxo (RXO) has 6 years of Invested Capital data on file, last reported at $2.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital fell 1.76% year-over-year to $2.0 billion; the trailing twelve-month figure through Mar 2026 stood at $2.0 billion (down 1.76% YoY), and the FY2025 full-year result was $1.9 billion, down 1.77% from the prior year.
• Invested Capital for Q1 2026 stood at $2.0 billion, up from $1.9 billion in the prior quarter.
• Across five years, Invested Capital topped out at $2.0 billion in Q3 2024 and bottomed at $949.0 million in Q1 2024.
• The 5-year median for Invested Capital is $1.1 billion (2022), against an average of $1.4 billion.
• The widest annual swing landed in 2023, when Invested Capital declined 12.93%; it then soared 109.8% in 2025.
• A 5-year view of Invested Capital shows it stood at $1.0 billion in 2022, then declined by 8.54% to $953.0 million in 2023, then soared by 107.76% to $2.0 billion in 2024, then dropped by 1.77% to $1.9 billion in 2025, then advanced by 0.57% to $2.0 billion in 2026.
• The last three Invested Capital figures came in at $2.0 billion (Q1 2026), $1.9 billion (Q4 2025), and $2.0 billion (Q3 2025), per Business Quant data.

Peer Comparison